...
首页> 外文期刊>Scientific reports. >Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer
【24h】

Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer

机译:通过Neuregulin 4基因转移预防高脂肪饮食诱导的肥胖症并提高胰岛素敏感性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Neuregulin 4 (NRG4), an epidermal growth factor-like signaling molecule, plays an important role in cell-to-cell communication during tissue development. Its function to regulate energy metabolism has recently been reported. This current study was designed to assess the preventive and therapeutic effects of NRG4 overexpression on high fat diet (HFD)-induced obesity. Using the hydrodynamic gene transfer method, we demonstrate that Nrg4 gene transfer in mice suppressed the development of diet-induced obesity, but did not affect pre-existing adiposity and body weight in obese mice. Nrg4 gene transfer curbed HFD-induced hepatic steatosis by inhibiting lipogenesis and PPARγ-mediated lipid storage. Concurrently, overexpression of NRG4 reduced chronic inflammation in both preventive and treatment studies, evidenced by lower mRNA levels of macrophage marker genes including F4/80, Cd68, Cd11b, Cd11c, and macrophage chemokine Mcp1, resulting in improved insulin sensitivity. Collectively, these results demonstrate that overexpression of the Nrg4 gene by hydrodynamic gene delivery prevents HFD-induced weight gain and fatty liver, alleviates obesity-induced chronic inflammation and insulin resistance, and supports the health benefits of NRG4 in managing obesity and obesity-associated metabolic disorders.
机译:Neuregulin 4(NRG4),一种表皮生长因子样信号分子,在组织发育期间在细胞对细胞通信中起重要作用。最近报道了其调节能量代谢的功能。本前研究旨在评估NRG4过表达对高脂饮食(HFD)诱导的肥胖症的预防和治疗效果。使用流体动力学基因转移方法,我们证明小鼠的NRG4基因转移抑制了饮食诱导的肥胖症的发展,但在肥胖小鼠中没有影响预先存在的肥胖和体重。 NRG4基因通过抑制脂肪生成和PPARγ介导的脂质储存来转移抑制HFD诱导的肝脏脂肪变性。同时,NRG4的过度表达在预防和治疗研究中减少慢性炎症,通过巨噬细胞标记基因的降低MRNA水平证明,包括F4 / 80,CD68,CD11b,CD11c和巨噬细胞趋化因子MCP1,导致胰岛素敏感性提高。总的来说,这些结果表明,通过流体动力学基因递送的NRG4基因的过表达可防止HFD诱导的体重增加和脂肪肝,缓解肥胖诱导的慢性炎症和胰岛素抗性,并支持NRG4管理肥胖和肥胖相关代谢的健康益处障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号